[The negotiation and bidding for the 2026 National Basic Medical Insurance Drug List concluded] September 9th, from September 5 to September 8, the National Medical Insurance Administration organized on-site negotiation and bidding for the 2026 National Basic Medical Insurance Drug List. Hundreds of domestic and foreign-funded enterprises participated on-site. 124 drugs outside the catalog were shortlisted for the negotiation and bidding process. Some innovative drugs in key areas such as tumors, rare diseases, chronic diseases, and children's medicines that are of social concern participated in the negotiation and are expected to be included in the medical insurance list. At the same time, the adjustment of the commercial health insurance innovative drug catalog was also carried out simultaneously, and 12 drugs were shortlisted for on-site price negotiation. The 2026 National Medical Insurance Drug Catalog and Commercial Insurance Innovative Drug Catalog are expected to be released in November this year and will be officially implemented on January 1, 2027. (CCTV News)